The effect of C3H mouse mammary tumour on the levels of serum and urine analytes in vivo
1985

Effects of Tumors on Mouse Blood and Urine Analytes

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): P.R.N. Kind, M. Gordon, M. Laverick, A.H.W. Nias, B.M. Slavin

Primary Institution: St. Thomas's Hospital Medical School

Hypothesis

Tumor-bearing mice will show different serum and urine analyte levels compared to normal mice.

Conclusion

Tumor-bearing mice exhibited lower levels of certain serum proteins and higher aspartate transaminase compared to normal mice.

Supporting Evidence

  • Serum total protein, alanine transaminase, and alkaline phosphatase were lower in tumor-bearing mice.
  • Aspartate transaminase was higher in tumor-bearing mice.
  • Urine protein and N-acetyl-β-D-glucosaminidase activity were lower in male tumor-bearing mice.
  • Alkaline phosphatase levels decreased with age in normal mice.
  • Significant differences were found between normal and tumor-bearing mice for several analytes.

Takeaway

Mice with tumors have different blood and urine test results than healthy mice, which helps us understand how cancer affects the body.

Methodology

C3H mice were implanted with mammary tumors, and serum and urine analytes were measured and compared with age and sex matched controls.

Potential Biases

Potential bias in the selection of control groups and the method of blood collection.

Limitations

The study may not account for all variables affecting analyte levels, and results are specific to the C3H mouse strain.

Participant Demographics

C3H mice, both male and female, aged 10-30 weeks.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication